ARKF vs XBI
ARK Fintech Innovation ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.75% for ARKF.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | ARKF | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.11% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $724M | $10.73B |
YTD return | -13.99% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.16 | 1.10 |
P/E ratio | 39.46 | — |
Last price | $41.40 | $164.01 |
Inception | — | — |
Issuer | ARK | State Street |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.46% |
| HOOD | Robinhood Markets Inc Class A | 6.26% |
| XYZ | Block Inc Class A | 6.07% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.23% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.88% |
| TOST | Toast Inc Class A | 4.44% |
| AMD | Advanced Micro Devices Inc | 3.95% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 3.95% |
| AMZN | Amazon.com Inc | 3.82% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $724M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.11%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 16.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.